Philadelphia, PA, United States of America

Lexus R Johnson

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Novartis Ag, The United States Government, University of Pennsylvania. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Lexus R Johnson

Introduction

Lexus R Johnson is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of immunology, particularly in the development of immune-enhancing therapies. With a total of 2 patents, his work focuses on advancing treatment options for diseases such as cancer.

Latest Patents

One of his latest patents is titled "Immunomodulatory RNA - Immune-enhancing RNAs for combination with chimeric antigen receptor therapy." This invention provides compositions and methods for treating various diseases, including cancer. It also relates to a method of administering chimeric antigen receptor (CAR) therapy alongside an additional therapeutic agent.

Career Highlights

Throughout his career, Lexus R Johnson has worked with prominent organizations, including Novartis AG and the United States Government. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

Lexus has collaborated with esteemed colleagues such as Andy J Minn and Carl H June. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Lexus R Johnson's contributions to immunology and cancer treatment through his patents and collaborations highlight his importance in the field of medical innovation. His work continues to pave the way for advancements in therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…